![glp-1 agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1/GIP Receptor Agonists and Diabetic](https://www.torhoermanlaw.com/wp-content/uploads/2024/09/GLP-1-Vision-Loss-MDL-3163.jpg)
glp-1 agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1/GIP Receptor Agonists and Diabetic
Description
Key points Obesity is a risk factor for developing osteoarthritis (OA), gout, rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), and is associated with higher disease activity and/or severity, and worse response to common treatments
![glp-1 agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1/GIP Receptor Agonists and Diabetic](https://www.reviewofoptometry.com/CMSImagesContent/2025/03/RO/RO_0325_059_table.jpg)
Specifically, Frias et al
![glp-1 agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1/GIP Receptor Agonists and Diabetic](https://www.ahajournals.org/cms/10.1161/CIRCULATIONAHA.122.059595/asset/ad09f9fb-0bf4-4c02-8c15-fe4df1f5a441/assets/graphic/circulationaha.122.059595.fig01.jpg)
Always remember that individual outcomes with the medication could vary, and some may experience different metabolic effects
![glp-1 agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1/GIP Receptor Agonists and Diabetic](https://ars.els-cdn.com/content/image/1-s2.0-S1043661824003463-ga1.jpg)
PubMed Wilding JPH, et al
![glp-1 agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1/GIP Receptor Agonists and Diabetic](https://e-dmj.org/upload/thumbnails/dmj-2025-0242f1.jpg)
The role of upstream lipid and metabolic systems in alzheimers disease, parkinsons disease and dementias
![glp-1 agonists blindness risk Ozempic Vision Loss Lawsuit [2026 Update] GLP-1/GIP Receptor Agonists and Diabetic](https://www.aoa.org/AOA/Images/News_2025/WIF_GLP1_1600x800_v1.png)
